Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
12,065,581
-
Share change
-
+916,232
-
Total reported value
-
$146,597,682
-
Price per share
-
$12.15
-
Number of holders
-
74
-
Value change
-
+$14,135,862
-
Number of buys
-
55
-
Number of sells
-
18
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q2 2015
As of 30 Jun 2015,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,065,581 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, FMR LLC, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, FRANKLIN RESOURCES INC, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, WALL STREET ASSOCIATES, TIVERTON ASSET MANAGEMENT LLC, EverPoint Asset Management, LLC, and Opaleye Management Inc..
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.